Logo image of JKS

JINKOSOLAR HOLDING CO-ADR (JKS) Stock Fundamental Analysis

NYSE:JKS - New York Stock Exchange, Inc. - US47759T1007 - ADR - Currency: USD

23.06  -0.62 (-2.62%)

After market: 23.21 +0.15 (+0.65%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to JKS. JKS was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While JKS is still in line with the averages on profitability rating, there are concerns on its financial health. JKS is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

In the past year JKS was profitable.
JKS had positive earnings in each of the past 5 years.
In multiple years JKS reported negative operating cash flow during the last 5 years.
JKS Yearly Net Income VS EBIT VS OCF VS FCFJKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B -10B -15B

1.2 Ratios

JKS has a Return On Assets (2.54%) which is in line with its industry peers.
With a decent Return On Equity value of 17.10%, JKS is doing good in the industry, outperforming 79.63% of the companies in the same industry.
The Return On Invested Capital of JKS (6.28%) is better than 69.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for JKS is significantly below the industry average of 11.67%.
The last Return On Invested Capital (6.28%) for JKS is above the 3 year average (3.11%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.54%
ROE 17.1%
ROIC 6.28%
ROA(3y)1.38%
ROA(5y)1.29%
ROE(3y)9.23%
ROE(5y)7.93%
ROIC(3y)3.11%
ROIC(5y)3.95%
JKS Yearly ROA, ROE, ROICJKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15 20 25

1.3 Margins

JKS has a Profit Margin (2.90%) which is comparable to the rest of the industry.
JKS's Profit Margin has improved in the last couple of years.
The Operating Margin of JKS (5.67%) is comparable to the rest of the industry.
JKS's Operating Margin has improved in the last couple of years.
JKS has a Gross Margin of 16.05%. This is amonst the worse of the industry: JKS underperforms 85.19% of its industry peers.
In the last couple of years the Gross Margin of JKS has grown nicely.
Industry RankSector Rank
OM 5.67%
PM (TTM) 2.9%
GM 16.05%
OM growth 3Y1.62%
OM growth 5Y16.57%
PM growth 3Y64.32%
PM growth 5Y12.37%
GM growth 3Y-2.97%
GM growth 5Y2.72%
JKS Yearly Profit, Operating, Gross MarginsJKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so JKS is still creating some value.
Compared to 1 year ago, JKS has more shares outstanding
JKS has more shares outstanding than it did 5 years ago.
JKS has a better debt/assets ratio than last year.
JKS Yearly Shares OutstandingJKS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
JKS Yearly Total Debt VS Total AssetsJKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B 100B

2.2 Solvency

Based on the Altman-Z score of 1.21, we must say that JKS is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.21, JKS is doing worse than 70.37% of the companies in the same industry.
JKS has a Debt/Equity ratio of 2.30. This is a high value indicating a heavy dependency on external financing.
With a Debt to Equity ratio value of 2.30, JKS is not doing good in the industry: 93.52% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Altman-Z 1.21
ROIC/WACC1.59
WACC3.96%
JKS Yearly LT Debt VS Equity VS FCFJKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10B -10B 20B

2.3 Liquidity

A Current Ratio of 1.04 indicates that JKS should not have too much problems paying its short term obligations.
The Current ratio of JKS (1.04) is worse than 91.67% of its industry peers.
JKS has a Quick Ratio of 1.04. This is a bad value and indicates that JKS is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.81, JKS is doing worse than 89.81% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.81
JKS Yearly Current Assets VS Current LiabilitesJKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B

More info and screens

6

3. Growth

3.1 Past

JKS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.24%.
JKS shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 56.68% yearly.
Looking at the last year, JKS shows a very strong growth in Revenue. The Revenue has grown by 42.08%.
Measured over the past years, JKS shows a very strong growth in Revenue. The Revenue has been growing by 36.50% on average per year.
EPS 1Y (TTM)-71.24%
EPS 3Y50.74%
EPS 5Y56.68%
EPS Q2Q%-97.16%
Revenue 1Y (TTM)42.08%
Revenue growth 3Y50.05%
Revenue growth 5Y36.5%
Sales Q2Q%-19.96%

3.2 Future

Based on estimates for the next years, JKS will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.44% on average per year.
Based on estimates for the next years, JKS will show a small growth in Revenue. The Revenue will grow by 2.71% on average per year.
EPS Next Y-87.9%
EPS Next 2Y-51.75%
EPS Next 3Y-18.43%
EPS Next 5Y9.44%
Revenue Next Year-17.76%
Revenue Next 2Y-4.41%
Revenue Next 3Y1.76%
Revenue Next 5Y2.71%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
JKS Yearly Revenue VS EstimatesJKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B 80B 100B
JKS Yearly EPS VS EstimatesJKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.06, the valuation of JKS can be described as reasonable.
Based on the Price/Earnings ratio, JKS is valued cheaper than 98.15% of the companies in the same industry.
JKS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 29.63.
Based on the Price/Forward Earnings ratio of 9.57, the valuation of JKS can be described as reasonable.
Based on the Price/Forward Earnings ratio, JKS is valued cheaper than 98.15% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.68. JKS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 8.06
Fwd PE 9.57
JKS Price Earnings VS Forward Price EarningsJKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JKS Per share dataJKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

A cheap valuation may be justified as JKS's earnings are expected to decrease with -18.43% in the coming years.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-51.75%
EPS Next 3Y-18.43%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 12.50%, JKS is a good candidate for dividend investing.
JKS's Dividend Yield is rather good when compared to the industry average which is at 2.23. JKS pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, JKS pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.5%

5.2 History

JKS does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
JKS Yearly Dividends per shareJKS Yearly Dividends per shareYearly Dividends per share 2023 2024 0.5 1

5.3 Sustainability

DP0%
EPS Next 2Y-51.75%
EPS Next 3Y-18.43%
JKS Yearly Income VS Free CF VS DividendJKS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5B -10B -15B

More info and screens

JINKOSOLAR HOLDING CO-ADR

NYSE:JKS (2/21/2025, 8:04:00 PM)

After market: 23.21 +0.15 (+0.65%)

23.06

-0.62 (-2.62%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-30 2024-10-30/bmo
Earnings (Next)03-18 2025-03-18/amc
Inst Owners24.49%
Inst Owner Change-1.84%
Ins Owners3.82%
Ins Owner ChangeN/A
Market Cap1.14B
Analysts48.57
Price Target28.47 (23.46%)
Short Float %70.27%
Short Ratio6.2
Dividend
Industry RankSector Rank
Dividend Yield 12.5%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)37.75%
Min EPS beat(2)-52.08%
Max EPS beat(2)127.59%
EPS beat(4)3
Avg EPS beat(4)151.74%
Min EPS beat(4)-52.08%
Max EPS beat(4)419.8%
EPS beat(8)4
Avg EPS beat(8)28.39%
EPS beat(12)7
Avg EPS beat(12)149.99%
EPS beat(16)9
Avg EPS beat(16)113.33%
Revenue beat(2)0
Avg Revenue beat(2)-85.51%
Min Revenue beat(2)-85.78%
Max Revenue beat(2)-85.25%
Revenue beat(4)0
Avg Revenue beat(4)-85.55%
Min Revenue beat(4)-85.78%
Max Revenue beat(4)-85.25%
Revenue beat(8)3
Avg Revenue beat(8)-29.72%
Revenue beat(12)4
Avg Revenue beat(12)-22.22%
Revenue beat(16)6
Avg Revenue beat(16)-16.68%
PT rev (1m)-1.08%
PT rev (3m)12.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)50.98%
EPS NY rev (3m)57.99%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-1.08%
Revenue NY rev (3m)-2.05%
Valuation
Industry RankSector Rank
PE 8.06
Fwd PE 9.57
P/S 0.07
P/FCF N/A
P/OCF N/A
P/B 0.41
P/tB 0.46
EV/EBITDA N/A
EPS(TTM)2.86
EY12.4%
EPS(NY)2.41
Fwd EY10.45%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS331.55
BVpS56.31
TBVpS49.63
PEG (NY)N/A
PEG (5Y)0.14
Profitability
Industry RankSector Rank
ROA 2.54%
ROE 17.1%
ROCE 11.97%
ROIC 6.28%
ROICexc 7.86%
ROICexgc 8.15%
OM 5.67%
PM (TTM) 2.9%
GM 16.05%
FCFM N/A
ROA(3y)1.38%
ROA(5y)1.29%
ROE(3y)9.23%
ROE(5y)7.93%
ROIC(3y)3.11%
ROIC(5y)3.95%
ROICexc(3y)3.83%
ROICexc(5y)5.06%
ROICexgc(3y)3.93%
ROICexgc(5y)5.22%
ROCE(3y)6.28%
ROCE(5y)7.66%
ROICexcg growth 3Y7.76%
ROICexcg growth 5Y17.64%
ROICexc growth 3Y7.69%
ROICexc growth 5Y17.77%
OM growth 3Y1.62%
OM growth 5Y16.57%
PM growth 3Y64.32%
PM growth 5Y12.37%
GM growth 3Y-2.97%
GM growth 5Y2.72%
F-ScoreN/A
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 2.3
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.81
Altman-Z 1.21
F-ScoreN/A
WACC3.96%
ROIC/WACC1.59
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.24%
EPS 3Y50.74%
EPS 5Y56.68%
EPS Q2Q%-97.16%
EPS Next Y-87.9%
EPS Next 2Y-51.75%
EPS Next 3Y-18.43%
EPS Next 5Y9.44%
Revenue 1Y (TTM)42.08%
Revenue growth 3Y50.05%
Revenue growth 5Y36.5%
Sales Q2Q%-19.96%
Revenue Next Year-17.76%
Revenue Next 2Y-4.41%
Revenue Next 3Y1.76%
Revenue Next 5Y2.71%
EBIT growth 1Y669.02%
EBIT growth 3Y52.48%
EBIT growth 5Y59.12%
EBIT Next Year-29.26%
EBIT Next 3Y4.46%
EBIT Next 5Y20.24%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A